A Role for Ceramide, but Not Diacylglycerol, in the Antagonism of Insulin Signal Transduction by Saturated Fatty Acids
Open accessThe DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Multiple studies suggest that lipid oversupply to skeletal muscle contributes to the development of insulin resistance, perhaps by promoting the accumulation of lipid metabolites capable of inhibiting signal transduction. Herein we demonstrate that exposing muscle cells to particular saturated free fatty acids (FFAs), but not mono-unsaturated FFAs, inhibits insulin stimulation of Akt/protein kinase B, a serine/threonine kinase that is a central mediator of insulin-stimulated anabolic metabolism. These saturated FFAs concomitantly induced the accumulation of ceramide and diacylglycerol, two products of fatty acyl-CoA that have been shown to accumulate in insulin-resistant tissues and to inhibit early steps in insulin signaling. Preventing de novo ceramide synthesis negated the antagonistic effect of saturated FFAs toward Akt/protein kinase B. Moreover, inducing ceramide buildup recapitulated and augmented the inhibitory effect of saturated FFAs. By contrast, diacylglycerol proved dispensable for these FFA effects. Collectively these results identify ceramide as a necessary and sufficient intermediate linking saturated fats to the inhibition of insulin signaling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In particular, an overabundance of SFA (e.g., Palmitate) can induce IR through the accumulation of lipid derivatives including DAGs, ceramides and long chain acyl-CoAs in the cytosol, which in turn can interfere with IRS1-PKB signalling [113,114,115,116,117,118].”
From Omega-3 Fatty Acids and Skeletal Muscle Health (2015) · cites this paper as [118]
Experimental — accuracy not yet measuredIn the citing paper
“The deleterious effect of ceramide on insulin signalling results from its ability to block the activation of AKT via two independent mechanisms (Chavez and Summers, 2012). The first mechanism involves the phosphorylation of AKT on pleckstrin homology domain by PKCζ, which in turn is activated by ceramide. This lowers the affinity of AKT for phosphoinositide (Powell et al., 2003) and blocks AKT”
From Mitochondrial (Dys)function and Insulin Resistance: From Pathophysiological Molecular Mechanisms to the Impact of Diet (2019) · cites this paper as Chavez et al., 2003
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093
Cho, H., Mu, J., Kim, J. K., Thorvaldsen, J. L., Chu, Q., Crenshaw, E. B., Kaestner, K. H., Bartolomei, M. S., Shulman, G. I., & Birnbaum, M. J. (2001) · Science · doi:10.1126/science.292.5522.1728 · Cited by 1,836
Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728
Yu, C., Chen, Y., Cline, G. W., Zhang, D., Zong, H., Wang, Y., Bergeron, R., Kim, J. K., Cushman, S. W., Cooney, G. J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200958200 · Cited by 1,561
McGarry, J. D. (2002) · Diabetes · doi:10.2337/diabetes.51.1.7 · Cited by 1,435
Itani, S. I., Ruderman, N. B., Schmieder, F., & Boden, G. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2005 · Cited by 1,390
Boden, G., & Shulman, G. I. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.32.s3.3.x · Cited by 1,300
Kohn, A. D., Summers, S. A., Birnbaum, M. J., & Roth, R. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31372 · Cited by 1,284
Self-citationPhosphoinositide 3-kinase: the key switch mechanism in insulin signalling
SHEPHERD, P. R., WITHERS, D. J., & SIDDLE, K. (1998) · Biochemical Journal · doi:10.1042/bj3330471 · Cited by 953
Measurement of Plasma Glucose, Free Fatty Acid, Lactate, and Insulin for 24 h in Patients With NIDDM
Reaven, G. M., Hollenbeck, C., Jeng, C.-Y., Wu, M. S., & Chen, Y.-D. I. (1988) · Diabetes · doi:10.2337/diab.37.8.1020 · Cited by 753
Research works printed but not linked: 5
- Chen, 1991, Trans. Assoc. Am. Physicians, 104, 206
- Motley, 2001, Cell. Mol. Biol. (Noisy-le-Grand), 47, 1059
- Minamide, 2003, Methods Cell Biol.
- Yang, 1991, Mol. Cell. Biol., 11, 1988
- Chin, 1994, Mol. Endocrinol., 8, 51
Cited by
Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
Eckel, R. H., Grundy, S. M., & Zimmet, P. Z. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66378-7 · Cited by 5,550
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
Koves, T. R., Ussher, J. R., Noland, R. C., Slentz, D., Mosedale, M., Ilkayeva, O., Bain, J., Stevens, R., Dyck, J. R. B., Newgard, C. B., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.013 · Cited by 1,990
Kim, J.-A., Montagnani, M., Koh, K. K., & Quon, M. J. (2006) · Circulation · doi:10.1161/circulationaha.105.563213 · Cited by 1,652
Akt signalling in health and disease
Hers, I., Vincent, E. E., & Tavaré, J. M. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.05.004 · Cited by 1,239
Holland, W. L., Brozinick, J. T., Wang, L.-P., Hawkins, E. D., Sargent, K. M., Liu, Y., Narra, K., Hoehn, K. L., Knotts, T. A., Siesky, A., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.01.002 · Cited by 1,232
“Phosphorylation of Akt/PKB was assessed by western blot using phosphospecific antibodies recognizing the activating serine 473 site.”
BackgroundMethodInfluentialSelf-citationGrundy, S. M. (2011) · Atlas of Atherosclerosis and Metabolic Syndrome · doi:10.1007/978-1-4419-5839-6_1 · Cited by 1,223
Ceramides in insulin resistance and lipotoxicity
SUMMERS, S. (2006) · Progress in Lipid Research · doi:10.1016/j.plipres.2005.11.002 · Cited by 848
Self-citationGlatz, J. F. C., Luiken, J. J. F. P., & Bonen, A. (2010) · Physiological Reviews · doi:10.1152/physrev.00003.2009 · Cited by 751
“However, intramuscular triacylglycerol depots are an indirect marker of insulin resistance, since the more soluble lipid metabolites such as ceramides, diacylglycerols, and long-chain fatty acyl-CoAs interfere with the postreceptor insulin signaling cascade (77, 78, 90, 193, 194, 410, 421).”
BackgroundThe aetiology and molecular landscape of insulin resistance
James, D. E., Stöckli, J., & Birnbaum, M. J. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00390-6 · Cited by 690
Holland, W. L., Bikman, B. T., Wang, L.-P., Yuguang, G., Sargent, K. M., Bulchand, S., Knotts, T. A., Shui, G., Clegg, D. J., Wenk, M. R., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43378 · Cited by 705
“Moreover, GCS inhibitors exacerbated palmitate antagonism of Akt/PKB in myocytes, coinciding with their enhancement of ceramide production (43).”
BackgroundSelf-citationCeramide Content Is Increased in Skeletal Muscle From Obese Insulin-Resistant Humans
Adams, J. M., Pratipanawatr, T., Berria, R., Wang, E., DeFronzo, R. A., Sullards, M. C., & Mandarino, L. J. (2004) · Diabetes · doi:10.2337/diabetes.53.1.25 · Cited by 668
“Recent studies have confirmed the role of ceramide in inhibition of Akt and downstream signaling, but not IRS-1 function, in 3T3-L1 adipocytes (33) or L6 muscle cells (34).”
BackgroundBays, H., Mandarino, L., & DeFronzo, R. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030723 · Cited by 664
“Lastly, increased muscle ceramide levels (secondary to increased long chain FA-CoAs) interfere with glucose transport and inhibit glycogen synthase in muscle via activation of protein kinase B (88, 89) (Fig.”
BackgroundUpdate on the effects of physical activity on insulin sensitivity in humans
Bird, S. R., & Hawley, J. A. (2017) · BMJ Open Sport & Exercise Medicine · doi:10.1136/bmjsem-2016-000143 · Cited by 646
“Conversely, evidence is accumulating for the view that ceramides (sphingolipid metabolites) 222 may be the causal link between saturated fatty acid content (but not unsaturated fats) in 223 skeletal muscle and impaired SI.[27, 28, 29] In the acute phase, exercise has been 224 demonstrated to increase serum ceramide [3…”
BackgroundA Ceramide-Centric View of Insulin Resistance
Chavez, J. A., & Summers, S. A. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.002 · Cited by 610
“In all cell types tested, however, ceramide blocks activation of Akt/PKB (Chavez et al., 2003; Powell et al., 2003; Salinas et al., 2000; Stratford et al., 2001; Stratford et al., 2004; Teruel et al., 2001; Zinda et al., 2001).”
BackgroundInfluentialSelf-citationSaturated fatty acids activate TLR-mediated proinflammatory signaling pathways
Huang, S., Rutkowsky, J. M., Snodgrass, R. G., Ono-Moore, K. D., Schneider, D. A., Newman, J. W., Adams, S. H., & Hwang, D. H. (2012) · Journal of Lipid Research · doi:10.1194/jlr.d029546 · Cited by 592
Holland, W. L., & Summers, S. A. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0025 · Cited by 595
“In C2C12 myotubes (13), PC12 neurons (207), brown adipocytes (208), or a human glioblastoma cell line (209), the PP2A inhibitor okadaic acid obviates the effects of ceramide on Akt/PKB.”
BackgroundInfluentialSelf-citationDe novo lipogenesis in the liver in health and disease: more than just a shunting yard for glucose
Sanders, F. W. B., & Griffin, J. L. (2016) · Biological Reviews · doi:10.1111/brv.12178 · Cited by 539
“Ceramides may also inhibit PKB action through stimulating its dephosphorylation and inactivation by PP2A (Chavez et al., 2003).”
BackgroundMcArdle, M. A., Finucane, O. M., Connaughton, R. M., McMorrow, A. M., & Roche, H. M. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00052 · Cited by 532
Korbecki, J., & Bajdak-Rusinek, K. (2019) · Inflammation Research · doi:10.1007/s00011-019-01273-5 · Cited by 509
“Activation of FFA1/GPR40 causes signal transduction through the PI3K =>PKB/Akt pathway, and the PLC =>PKC => p38/ERK–MAPK pathway, which causes phosphorylation and degradation of IκBα [181].”
BackgroundRole of changes in cardiac metabolism in development of diabetic cardiomyopathy
An, D., & Rodrigues, B. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00278.2006 · Cited by 446
“FA derivatives, such as fatty acyl CoA, diacylglycerol , or ceramide may activate a serine kinase cascade, which involves protein kinase C- and IB kinase- (inhibitor of NF-B kinase-), leading to serine phosphorylation of IRS (44, 114, 128, 129, 269).”
BackgroundInfluentialCeramides as modulators of cellular and whole-body metabolism
Bikman, B. T., & Summers, S. A. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57144 · Cited by 419
Self-citationSphingolipids and phospholipids in insulin resistance and related metabolic disorders
Meikle, P. J., & Summers, S. A. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.169 · Cited by 423
Self-citationNakamura, S., Takamura, T., Matsuzawa-Nagata, N., Takayama, H., Misu, H., Noda, H., Nabemoto, S., Kurita, S., Ota, T., Ando, H., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m901488200 · Cited by 426
Ceramide is a cardiotoxin in lipotoxic cardiomyopathy
Park, T.-S., Hu, Y., Noh, H.-L., Drosatos, K., Okajima, K., Buchanan, J., Tuinei, J., Homma, S., Jiang, X.-C., Abel, E. D., et al. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800147-jlr200 · Cited by 411
PGC-1α regulation by exercise training and its influences on muscle function and insulin sensitivity
Lira, V. A., Benton, C. R., Yan, Z., & Bonen, A. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00755.2009 · Cited by 412
Regulation of Insulin Action by Ceramide
Stratford, S., Hoehn, K. L., Liu, F., & Summers, S. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406499200 · Cited by 410
Self-citationDose-Response Effect of Elevated Plasma Free Fatty Acid on Insulin Signaling
Belfort, R., Mandarino, L., Kashyap, S., Wirfel, K., Pratipanawatr, T., Berria, R., DeFronzo, R. A., & Cusi, K. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1640 · Cited by 404
“Studies in vitro (25– 27,31,66) and in vivo (28,29,32,33,37,38) in animals and humans have provided evidence that increased levels of long-chain fatty acyl CoAs, ceramides, and diacylglycerol can all inhibit the insulin signaling cascade.”
BackgroundCeramides in Metabolism: Key Lipotoxic Players
Chaurasia, B., & Summers, S. A. (2021) · Annual Review of Physiology · doi:10.1146/annurev-physiol-031620-093815 · Cited by 343
“, inhibition of insulin signaling and/or glucose uptake) (8, 9, 11, 119, 135, 147).”
BackgroundSelf-citationSphingolipids produced by gut bacteria enter host metabolic pathways impacting ceramide levels
Johnson, E. L., Heaver, S. L., Waters, J. L., Kim, B. I., Bretin, A., Goodman, A. L., Gewirtz, A. T., Worgall, T. S., & Ley, R. E. (2020) · Nature Communications · doi:10.1038/s41467-020-16274-w · Cited by 352
Beyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication
Funcke, J.-B., & Scherer, P. E. (2019) · Journal of Lipid Research · doi:10.1194/jlr.r094060 · Cited by 327
Xia, J. Y., Holland, W. L., Kusminski, C. M., Sun, K., Sharma, A. X., Pearson, M. J., Sifuentes, A. J., McDonald, J. G., Gordillo, R., & Scherer, P. E. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.06.007 · Cited by 348
“Similarly, overexpression of acid ceramidase in cultured cells prevents saturated fatty acids from impairing insulin action in cultured C2C12 myotubes (Chavez et al., 2003).”
Benoit, S. C., Kemp, C. J., Elias, C. F., Abplanalp, W., Herman, J. P., Migrenne, S., Lefevre, A.-L., Cruciani-Guglielmacci, C., Magnan, C., Yu, F., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36714 · Cited by 351
The metabolism and function of sphingolipids and glycosphingolipids
Lahiri, S., & Futerman, A. H. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7076-0 · Cited by 344
Sergi, D., Naumovski, N., Heilbronn, L. K., Abeywardena, M., O’Callaghan, N., Lionetti, L., & Luscombe-Marsh, N. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00532 · Cited by 347
Obesity-related derangements in metabolic regulation
Muoio, D. M., & Newgard, C. B. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.103004.142512 · Cited by 345
Sphingolipids in metabolic disease: The good, the bad, and the unknown
Green, C. D., Maceyka, M., Cowart, L. A., & Spiegel, S. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.06.006 · Cited by 327
Colca, J. R., McDonald, W. G., Waldon, D. J., Leone, J. W., Lull, J. M., Bannow, C. A., Lund, E. T., & Mathews, W. R. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00424.2003 · Cited by 338
“The buildup of long-chain acyl-CoA esters could result in insulin resistance by a number of mechanisms, including activation of specific protein kinase C isoforms (50) or generation of ceramide (7).”
BackgroundSkeletal muscle lipid deposition and insulin resistance: effect of dietary fatty acids and exercise
Corcoran, M. P., Lamon-Fava, S., & Fielding, R. A. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.3.662 · Cited by 341
“sis as well as inhibit Akt activation (117, 119, 177).”
BackgroundWang, D. D., Toledo, E., Hruby, A., Rosner, B. A., Willett, W. C., Sun, Q., Razquin, C., Zheng, Y., Ruiz-Canela, M., Guasch-Ferré, M., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.024261 · Cited by 327
Lee, J. S., Pinnamaneni, S. K., Eo, S. J., Cho, I. H., Pyo, J. H., Kim, C. K., Sinclair, A. J., Febbraio, M. A., & Watt, M. J. (2006) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01438.2005 · Cited by 325
“The biochemical and molecular processes linking saturated fats to insulin resistance remain unresolved but may relate to altered membrane phospholipid fatty acid composition and membrane fluidity and stability (43), changes in lipogenic gene transcription (10), the type of fatty acids within TAG (2, 28), and direct in…”
BackgroundInfluentialFatty Acid-Induced Lipotoxicity in Pancreatic Beta-Cells During Development of Type 2 Diabetes
Oh, Y. S., Bae, G. D., Baek, D. J., Park, E.-Y., & Jun, H.-S. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00384 · Cited by 306
“Inhibition of ceramide biosynthesis restores Akt activation (52), and Akt inactivation with ceramide accumulation is observed in human treated with saturated fat (53).”
BackgroundRetinoid X receptors: X-ploring their (patho)physiological functions
Szanto, A., Narkar, V, Shen, Q., Uray, I. P., Davies, P. J. A., & Nagy, L. (2004) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401533 · Cited by 302
The Role of Ceramides in Insulin Resistance
Sokolowska, E., & Blachnio-Zabielska, A. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00577 · Cited by 297
“Moreover, ceramides indirectly suppress the PKB/Akt activity by stimulation of PP2A (73).”
BackgroundInfluentialThe emerging role of HDL in glucose metabolism
Drew, B. G., Rye, K.-A., Duffy, S. J., Barter, P., & Kingwell, B. A. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.235 · Cited by 307
“Elegant in vitro models demonstrate insulin resistance in muscle cells either by treatment of cells with fatty acid”
BackgroundThe Pathogenesis of Obesity-Associated Adipose Tissue Inflammation
Engin, A. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-48382-5_9 · Cited by 287
Bo, T., Gao, L., Yao, Z., Shao, S., Wang, X., Proud, C. G., & Zhao, J. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.04.006 · Cited by 293
Aging Up-Regulates Expression of Inflammatory Mediators in Mouse Adipose Tissue
Wu, D., Ren, Z., Pae, M., Guo, W., Cui, X., Merrill, A. H., & Meydani, S. N. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.7.4829 · Cited by 287
“Both lipid messenger ceramide (24, 26, 29, 46, 47) and inflammatory cytokine IL-6 (48–52) and TNF- (53–57) have been shown to induce insulin resistance.”
BackgroundPhysical inactivity as the culprit of metabolic inflexibility: evidence from bed-rest studies
Bergouignan, A., Rudwill, F., Simon, C., & Blanc, S. (2011) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00698.2011 · Cited by 274
Activation of Protein Phosphatase 2A by Palmitate Inhibits AMP-activated Protein Kinase
Wu, Y., Song, P., Xu, J., Zhang, M., & Zou, M.-H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608310200 · Cited by 274
RetractedDubé, J. J., Amati, F., Toledo, F. G. S., Stefanovic-Racic, M., Rossi, A., Coen, P., & Goodpaster, B. H. (2011) · Diabetologia · doi:10.1007/s00125-011-2065-0 · Cited by 271
“While cell-system and animal studies have demonstrated that these lipids can cause insulin resistance in particular situations [17, 19], studies in humans have only provided circumstantial, and contradictory, evidence regarding their potential role in”
BackgroundResultMacrophages, Chronic Inflammation, and Insulin Resistance
Li, H., Meng, Y., He, S., Tan, X., Zhang, Y., Zhang, X., Wang, L., & Zheng, W. (2022) · Cells · doi:10.3390/cells11193001 · Cited by 264
“Ceramide is mainly involved in the development of insulin resistance from two aspects: ceramide signal stimulates the binding of PKCζ and AKT, making AKT unable to bind phosphatidylinositol (3,4,5) -triphosphate (PIP3), thereby inhibiting insulin signaling [190]; on the other hand, ceramide activates protein phosphata…”
BackgroundSelf-citationThe Inflammasome Puts Obesity in the Danger Zone
Stienstra, R., Tack, C. J., Kanneganti, T.-D., Joosten, L. A. B., & Netea, M. G. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2011.10.011 · Cited by 271
Weigert, C., Brodbeck, K., Staiger, H., Kausch, C., Machicao, F., Häring, H. U., & Schleicher, E. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312692200 · Cited by 269
POWELL, D. J., TURBAN, S., GRAY, A., HAJDUCH, E., & HUNDAL, H. S. (2004) · Biochemical Journal · doi:10.1042/bj20040139 · Cited by 267
Straczkowski, M., Kowalska, I., Nikolajuk, A., Dzienis-Straczkowska, S., Kinalska, I., Baranowski, M., Zendzian-Piotrowska, M., Brzezinska, Z., & Gorski, J. (2004) · Diabetes · doi:10.2337/diabetes.53.5.1215 · Cited by 260
“Effect of SFAs on PKB/Akt inactivation was negated by preventing de novo ceramide synthesis (46).”
BackgroundEngin, A. B. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-48382-5_8 · Cited by 260
Acylcarnitines: potential implications for skeletal muscle insulin resistance
Aguer, C., McCoin, C. S., Knotts, T. A., Thrush, A. B., Ono‐Moore, K., McPherson, R., Dent, R., Hwang, D. H., Adams, S. H., & Harper, M. (2015) · The FASEB Journal · doi:10.1096/fj.14-255901 · Cited by 240
“For Western blots, C2C12 myotubes were then treated for 2 h with DMEM containing 2% BSA followed by 100 nmol/L insulin stimulation for 10 min (23).”
MethodSelf-citationRole of intramyocelluar lipids in human health
Coen, P. M., & Goodpaster, B. H. (2012) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.05.009 · Cited by 252
“In muscle, ceramide has been identified as a key mediator of IR via inhibition of the serine/threonine-specific protein kinase Akt/protein kinase B (PKB) [45], an important intermediate linking insulin signaling to GLUT4 translocation to the sarcolemma, potentially via protein phosphatase 2 (PP2)- and protein kinase C…”
BackgroundInfluentialInduction of proinflammatory cytokines by long-chain saturated fatty acids in human macrophages
Håversen, L., Danielsson, K. N., Fogelstrand, L., & Wiklund, O. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.05.033 · Cited by 237
“Ceramide is a specific metabolite of long-chain SFA, such as palmitate and stearate [28].”
BackgroundSphingolipids and Lipoproteins in Health and Metabolic Disorders
Iqbal, J., Walsh, M. T., Hammad, S. M., & Hussain, M. M. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2017.03.005 · Cited by 237
The effects of obesity on skeletal muscle regeneration
Akhmedov, D., & Berdeaux, R. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00371 · Cited by 241
“In C2C12 myoblasts, 3T3-L1 adipocytes and PC-12 cells, ceramides activate protein phosphatase 2A, leading to Akt dephosphorylation (Salinas et al., 2000; Cazzolli et al., 2001; Chavez et al., 2003; Stratford et al., 2004).”
BackgroundZhang, Q.-J., Holland, W. L., Wilson, L., Tanner, J. M., Kearns, D., Cahoon, J. M., Pettey, D., Losee, J., Duncan, B., Gale, D., et al. (2012) · Diabetes · doi:10.2337/db11-1399 · Cited by 234
“We focused on PP2A, given earlier reports that ceramide increases PP2A activity (14,30,36).”
BackgroundSelf-citationO’Connor, J. C., McCusker, R. H., Strle, K., Johnson, R. W., Dantzer, R., & Kelley, K. W. (2008) · Cellular Immunology · doi:10.1016/j.cellimm.2007.09.010 · Cited by 238
“Ceramide was shown to inhibit insulin-induced Akt phosphorylation in C2C12 myotubes [124] and block PDGF-induced Akt phosphorylation and [3H]-thymidine incorporation in smooth muscle cells [125].”
BackgroundZhao, H., Przybylska, M., Wu, I.-H., Zhang, J., Siegel, C., Komarnitsky, S., Yew, N. S., & Cheng, S. H. (2007) · Diabetes · doi:10.2337/db06-0719 · Cited by 238
Dysfunctional fat cells, lipotoxicity and type 2 diabetes
Defronzo, R. A. (2004) · International Journal of Clinical Practice · doi:10.1111/j.1368-504x.2004.00389.x · Cited by 236
Ohmura, K., Ishimori, N., Ohmura, Y., Tokuhara, S., Nozawa, A., Horii, S., Andoh, Y., Fujii, S., Iwabuchi, K., Onoé, K., et al. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.198614 · Cited by 215
From chronic overnutrition to insulin resistance: The role of fat-storing capacity and inflammation
Lionetti, L., Mollica, M. P., Lombardi, A., Cavaliere, G., Gifuni, G., & Barletta, A. (2009) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2008.10.010 · Cited by 216
Increased skeletal muscle ceramide level in men at risk of developing type 2 diabetes
Straczkowski, M., Kowalska, I., Baranowski, M., Nikolajuk, A., Otziomek, E., Zabielski, P., Adamska, A., Blachnio, A., Gorski, J., & Gorska, M. (2007) · Diabetologia · doi:10.1007/s00125-007-0781-2 · Cited by 218
“Experimental studies revealed that even relatively small changes in the tissue ceramide level are sufficient to antagonise insulin action [36].”
BackgroundChavez, J. A., Holland, W. L., Bär, J., Sandhoff, K., & Summers, S. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412769200 · Cited by 219
Self-citationSinha, S., Perdomo, G., Brown, N. F., & O'Doherty, R. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406514200 · Cited by 215
Metabolic syndrome as a risk factor for neurological disorders
Farooqui, A. A., Farooqui, T., Panza, F., & Frisardi, V. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0840-1 · Cited by 207
“Exposing muscle cells to palmitate not only elevates ceramide synthesis and inhibits insulin-mediated stimulation of Akt/protein kinase B, but also negates the antagonistic effect of saturated free fatty acids toward Akt/PKB [105].”
BackgroundPeng, G., Li, L., Liu, Y., Pu, J., Zhang, S., Yu, J., Zhao, J., & Liu, P. (2011) · Endocrinology · doi:10.1210/en.2010-1369 · Cited by 201
PI3K/Akt signaling requires spatial compartmentalization in plasma membrane microdomains
Gao, X., Lowry, P. R., Zhou, X., Depry, C., Wei, Z., Wong, G. W., & Zhang, J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019386108 · Cited by 195
“However, ceramide has also been shown to promote the dephosphorylation of Akt by activating the Akt phosphatase, protein phosphatase 2A (PP2A), one of the earliest known ceramide targets (31, 32).”
BackgroundRole of ceramide in diabetes mellitus: evidence and mechanisms
Galadari, S., Rahman, A., Pallichankandy, S., Galadari, A., & Thayyullathil, F. (2013) · Lipids in Health and Disease · doi:10.1186/1476-511x-12-98 · Cited by 195
“Insulin receptor is a tyrosine kinase receptor which has two extracellular α-subunits, and two transmem- IRS PI3K Akt PDK1 Akt Insulin IR PIP2 PIP3 FOXO1 GSK3”
BackgroundInfluentialOmega-3 Fatty Acids and Skeletal Muscle Health
Jeromson, S., Gallagher, I., Galloway, S., & Hamilton, D. (2015) · Marine Drugs · doi:10.3390/md13116977 · Cited by 203
“including DAGs, ceramides and long chain acyl-coAs in the cytosol, which in turn can interfere with IRS1-PKB signalling [113–118].”
BackgroundSphingolipid Metabolic Pathway: An Overview of Major Roles Played in Human Diseases
Pralhada Rao, R., Vaidyanathan, N., Rengasamy, M., Mammen Oommen, A., Somaiya, N., & Jagannath, M. R. (2013) · Journal of Lipids · doi:10.1155/2013/178910 · Cited by 191
“Decreasing the levels of ceramide by using inhibitors can restore the insulin sensitivity in lipid induced insulin resistant cell culture [33, 34].”
BackgroundInflammation links excess fat to insulin resistance: the role of the interleukin‐1 family
Tack, C. J., Stienstra, R., Joosten, L. A. B., & Netea, M. G. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01145.x · Cited by 193
“Moreover, unsaturated fatty acids lack the ability to activate TLR4 or evoke ceramide synthesis (35, 37) and may thus prevent activation of either the first or the second signal of IL-1b production.”
BackgroundProtective Role of Autophagy in Palmitate-Induced INS-1 β-Cell Death
Choi, S.-E., Lee, S.-M., Lee, Y.-J., Li, L.-J., Lee, S.-J., Lee, J.-H., Kim, Y., Jun, H.-S., Lee, K.-W., & Kang, Y. (2009) · Endocrinology · doi:10.1210/en.2008-0483 · Cited by 193
“Ceramide has been suggested to be an important mediator of FFA-induced -cell death (2, 3, 6, 7).”
InfluentialCerS1-Derived C18:0 Ceramide in Skeletal Muscle Promotes Obesity-Induced Insulin Resistance
Turpin-Nolan, S. M., Hammerschmidt, P., Chen, W., Jais, A., Timper, K., Awazawa, M., Brodesser, S., & Brüning, J. C. (2019) · Cell Reports · doi:10.1016/j.celrep.2018.12.031 · Cited by 190
Summers, S. A., & Nelson, D. H. (2005) · Diabetes · doi:10.2337/diabetes.54.3.591 · Cited by 185
“[23,24]”
BackgroundInfluentialSelf-citationGao, Z., Zhang, J., Kheterpal, I., Kennedy, N., Davis, R. J., & Ye, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.228874 · Cited by 187
Tardif, N., Salles, J., Guillet, C., Tordjman, J., Reggio, S., Landrier, J., Giraudet, C., Patrac, V., Bertrand‐Michel, J., Migne, C., et al. (2014) · Aging Cell · doi:10.1111/acel.12263 · Cited by 186
“The concentration of palmitate used in this study is comparable with that found physiologically and is similar to that used in earlier studies evaluating FFA effects in both immortalized muscle cells (Schmitz-Peiffer et al., 1999; Storz et al., 1999; Chavez et al., 2003) and isolated skeletal muscle strips (Thompson e…”
BackgroundResultInfluentialZonation of glucose and fatty acid metabolism in the liver: Mechanism and metabolic consequences
Hijmans, B. S., Grefhorst, A., Oosterveer, M. H., & Groen, A. K. (2014) · Biochimie · doi:10.1016/j.biochi.2013.06.007 · Cited by 169
Food Polyphenols and Type II Diabetes Mellitus: Pharmacology and Mechanisms
Naz, R., Saqib, F., Awadallah, S., Wahid, M., Latif, M. F., Iqbal, I., & Mubarak, M. S. (2023) · Molecules · doi:10.3390/molecules28103996 · Cited by 163
Jové, M., Planavila, A., Sánchez, R. M., Merlos, M., Laguna, J. C., & Vázquez-Carrera, M. (2006) · Endocrinology · doi:10.1210/en.2005-0440 · Cited by 172
“cells (19, 24) because concentrations of FFA up to 2 mm are”
BackgroundLipid oversupply, selective insulin resistance, and lipotoxicity: Molecular mechanisms
Chavez, J. A., & Summers, S. A. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.09.015 · Cited by 169
Self-citationde la Monte, S. M., Longato, L., Tong, M., & Wands, J. R. (2009) · PubMed · Cited by 190
N-acylethanolamines, anandamide and food intake
Hansen, H. S., & Diep, T. A. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.04.024 · Cited by 164
Turpin, S. M., Lancaster, G. I., Darby, I., Febbraio, M. A., & Watt, M. J. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00095.2006 · Cited by 164
“Studies in cardiac and pancreatic -cells have demonstrated that lipoapoptosis leads to loss of tissue function (11, 35).”
InfluentialDobrzyn, A., Dobrzyn, P., Lee, S.-H., Miyazaki, M., Cohen, P., Asilmaz, E., Hardie, D. G., Friedman, J. M., & Ntambi, J. M. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00439.2004 · Cited by 161
Lipke, K., Kubis-Kubiak, A., & Piwowar, A. (2022) · Cells · doi:10.3390/cells11050844 · Cited by 182
“During the study, murine myotubes were incubated with 750 μM palmitate for 16 h [54].”
MethodMuscular diacylglycerol metabolism and insulin resistance
Timmers, S., Schrauwen, P., & de Vogel, J. (2008) · Physiology & Behavior · doi:10.1016/j.physbeh.2007.12.002 · Cited by 161
“Moreover, blocking ceramide synthesis in palmitate-treated myotubes, restored Akt activation by insulin [65].”
BackgroundBradley, R. L., Fisher, F. M., & Maratos‐Flier, E. (2008) · Obesity · doi:10.1038/oby.2008.39 · Cited by 160
“Fatty acid–containing media was prepared by conjugation of each fatty acid to fatty acid–free BSA as described previously (36).”
MethodShao-Ling, W. A. N. G., Ying, L. I., Wen, Y., Yan-Feng, C. H. E. N., Na, L.-X., Li, S., & Sun, C. (2009) · Biomedical and Environmental Sciences · doi:10.1016/s0895-3988(09)60019-2 · Cited by 176
Moro, C., Galgani, J. E., Luu, L., Pasarica, M., Mairal, A., Bajpeyi, S., Schmitz, G., Langin, D., Liebisch, G., & Smith, S. R. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0053 · Cited by 148
“Thus, ceramide synthesis is not affected by mono- or polyunsaturated fat (13).”
BackgroundColistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections
Bassetti, M., Repetto, E., Righi, E., Boni, S., Diverio, M., Molinari, M. P., Mussap, M., Artioli, S., Ansaldi, F., Durando, P., et al. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm509 · Cited by 163
Mitochondrial CoQ deficiency is a common driver of mitochondrial oxidants and insulin resistance
Fazakerley, D. J., Chaudhuri, R., Yang, P., Maghzal, G. J., Thomas, K. C., Krycer, J. R., Humphrey, S. J., Parker, B. L., Fisher-Wellman, K. H., Meoli, C. C., et al. (2018) · eLife · doi:10.7554/elife.32111 · Cited by 160
“For example, stresses such as lipotoxicity (Chavez et al., 2003; Griffin et al., 1999), endoplasmic reticulum stress (Ozcan et al., 2004), mitochondrial dysfunction (Kelley et al., 2002; Montgomery and Turner, 2015) and mitochondrial oxidative stress (Anderson et al., 2009; Hoehn et al.,…”
BackgroundShah, C., Yang, G., Lee, I., Bielawski, J., Hannun, Y. A., & Samad, F. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709950200 · Cited by 155
Metadata
- Authors
- Chavez, J. A., Knotts, T. A., Wang, L.-P., Li, G., Dobrowsky, R. T., Florant, G. L., & Summers, S. A.
- Affiliations
- Colorado State University (US)
- University of Kansas (US)
- Corresponding author
- Summers, Scott A.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-03
- Volume
- 278
- Issue
- 12
- Pages
- 10297-10303
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1984413737
- Cited by
- 617
- References
- 67
- Citations by year
- 2026: 11 · 2025: 11 · 2024: 19 · 2023: 15 · 2022: 18 · 2021: 36 · 2020: 30 · 2019: 25 · 2018: 27 · 2017: 38 · 2016: 32 · 2015: 31 · 2014: 29 · 2013: 33 · 2012: 44
- FWCI
- 6.86
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6424 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- March of Dimes Foundation
- American Heart Association
- Colorado State University
- National Institutes of Health (5r21dk059749-02, 5r21dk060676-02)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK59749, R21-DK60676, R01DK058784)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- ceramide, diacylglycerol, saturated fatty acids, insulin resistance, insulin signaling, Akt/protein kinase B, skeletal muscle, de novo ceramide synthesis, monounsaturated fatty acids
- MeSH terms
- Glycogen Synthase Kinase 3 beta, Animals, Cells, Cultured, Ceramides, Diglycerides, Fatty Acids, Fatty Acids, Nonesterified, Insulin, Phosphorylation, Proto-Oncogene Proteins, Signal Transduction, Protein Serine-Threonine Kinases, Muscle, Skeletal, Glycogen Synthase Kinase 3, Proto-Oncogene Proteins c-akt, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.